080720 — Union Korea Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Union Korea Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	51,264	50,379	48,304	61,293	63,169
Cost of Revenue
Gross Profit	24,326	19,352	15,239	24,019	20,897
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	50,202	61,353	59,452	59,994	75,380
Operating Profit	1,063	-10,974	-11,148	1,300	-12,211
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	586	-12,084	-14,477	944	-14,404
Provision for Income Taxes
Net Income After Taxes	411	-9,322	-11,109	-932	-18,156
Net Income Before Extraordinary Items
Net Income	411	-9,322	-11,109	-932	-18,156
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	410	-9,322	-11,109	-932	-18,156
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	32.1	-1,386	-1,386	-129	-1,898
Dividends per Share